复星医药:拟5.17亿港元增持控股子公司复宏汉霖3.87%股权

人民财讯
21 Apr

  人民财讯4月21日电,复星医药(600196)4月21日晚间公告,2025年4月11日至17日期间,公司控股子公司复星医药产业与上海善梧、无锡通善、舟山果运及Henlink分别签订转让协议,复星医药产业拟以港币24.60元/股的价格受让该等卖方持有的合计2103.43万股复宏汉霖非上市股份(约占截至本公告日期复宏汉霖股份总数的3.87%),转让价款共计港币5.17亿元(或等值人民币)。本次增持完成后,本集团持有复宏汉霖的股权比例将增至63.43%(本次增持前为59.56%)。

(文章来源:人民财讯)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10